Layka Bio Inc filed a Form D with the Securities and Exchange Commission on 2026-08-07.
Layka Bio Inc filed a Form D notice of an exempt securities offering with the SEC on August 7, 2026. The filing reports $300K sold. Its industry group is Biotechnology. It names Ante Lundberg (Executive Officer, Director, Promoter) (SEC Form D, August 7, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Layka Bio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Layka Bio Inc.
Free to see. No signup.
More on the people and the money behind Layka Bio Inc, from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in August 2026, largest first.
Get an email when Layka Bio Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Layka Bio Inc raises, hires or launches. No email unless you switch it on.
Watch Layka Bio Inc →Get the full cited report on Layka Bio Inc
What the filing shows about Layka Bio Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Layka Bio Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Layka Bio Inc's address as 19 Terrace Ave, Newton Highlands, MA 02461.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Layka Bio Inc is a registered filer with the SEC (CIK 2148283) and has filed since 2026-08-07. 1 filing is on record, the latest on 2026-08-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Layka Bio Inc's Form D of 2026-08-07 names Ante Lundberg, Matthew Meyerson and Stephen Kron as its officers, directors or promoters.
Its new offerings report $300K sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $300K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Ante Lundberg is named as Executive Officer and Director and Promoter on the Form D that Layka Bio Inc filed with the SEC on 7 August 2026, one of 3 people that filing names.
Matthew Meyerson is named as Promoter on the Form D that Layka Bio Inc filed with the SEC on 7 August 2026, one of 3 people that filing names.
Stephen Kron is named as Promoter on the Form D that Layka Bio Inc filed with the SEC on 7 August 2026, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 named in another capacity.
Named as of the 2026-08-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Layka Bio Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Layka Bio Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Layka Bio Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Layka Bio IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Layka Bio Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Layka Bio Inc. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-08-03 · Biotech raises, week of 2026-08-03
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/layka-bio-inc-form-d-26000001